Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Stanford University Pfizer |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00880581 |
To assess the feasibility of using intra-tumoral PF-3512676 in combination with local radiation as a therapy for lowgrade b-cell lymphoma.
Condition | Intervention | Phase |
---|---|---|
Lymphoma |
Drug: PF-3512676 Radiation: Local radiation |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase II Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas |
Estimated Enrollment: | 30 |
Study Start Date: | September 2008 |
Estimated Study Completion Date: | December 2011 |
Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Required wash out periods for prior therapy:
Exclusion Criteria:
Contact: Emily Troutner | (650) 725-4968 | troutner@stanford.edu |
United States, California | |
Stanford University School of Medicine | Recruiting |
Stanford, California, United States, 94305 | |
Contact: Emily Troutner 650-725-4968 troutner@stanford.edu | |
Contact: Lori Richards (650) 725-4968 lorir@stanford.edu | |
Principal Investigator: Ronald Levy | |
Sub-Investigator: Joshua Brody |
Principal Investigator: | Ronald Levy | Stanford University |
Responsible Party: | Stanford University School of Medicine ( Ronald Levy, Principal Investigator ) |
Study ID Numbers: | SU-03272009-2038, LYMNHL0064 |
Study First Received: | April 10, 2009 |
Last Updated: | April 13, 2009 |
ClinicalTrials.gov Identifier: | NCT00880581 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Lymphoma, B-Cell Lymphatic Diseases Immunoproliferative Disorders B-cell Lymphomas |
Lymphoma, Non-Hodgkin Lymphoproliferative Disorders Lymphoma |
Lymphoma, B-Cell Lymphatic Diseases Neoplasms Immunoproliferative Disorders Neoplasms by Histologic Type |
Immune System Diseases Lymphoma, Non-Hodgkin Lymphoproliferative Disorders Lymphoma |